ReviewExpert opinion on therapeutic targets2021

Hypoplastic left heart syndrome (HLHS): molecular pathogenesis and emerging drug targets for cardiac repair and regeneration.

Anthony T Bejjani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.